http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2017741-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef5045e7639c28010832b4eae012eb1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
filingDate 1990-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12ed64ba7b7504a61beb2035bf82719c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde5acbd01ca69d3e599bd1973e615f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7ca4939430f4aa1fa93a85b2bb3f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85e6bc4beb1ac9c52a904991afc7596
publicationDate 1991-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2017741-A1
titleOfInvention Platinum triamine antitumor agents containing substituted anilines
abstract ABSTRACT OF THE DISCLOSURE Platinum (II) antitumor agents of the general formula: Y wherein A1 and A2 are the same or different and are selected from ammonia or a monodentate amine and substituted monodentate amines, or A1 and A2 together are a diamine represented by the general formula: wherein R2 and R3 are the same or different and are each selected from hydrogen, linear or branched C1-C6 alkyl and substituted linear or branched C1-C6 alkyl wherein the substituents are selected from hydroxy, C1-C4 alkoxy, halo, carboxy, C1-C4 alkylcarboxy or C1-C4 alkoxylcarbonyl, or R2 and R3, taken together, form a 1,2-diaminocycloalkane containing 4-8 nuclear carbon atoms or a substituted 1,2-diaminocycloalkane wherein the substituents are selected from linear or branched C1-C6 alkyl groups, hydroxy, C1-C4 alkoxy, halo, carboxy, C1-C4 alkylcarboxy or C1-C4 alkoxylcarbonyl; wherein L is aniline or aniline substituted with one or more of C1-C6 linear or branched alkyl, hydroxy, C1-C4 alkoxy, halo, carboxy, cyano, isocyano, phenyl, nitro, C1-C4 alkylcarboxy or C1-C4 alkoxylcarbonyl; wherein X is a monodentate anionic ligand and wherein Y is an anion. Members of this class of compounds have demonstrated activity in a number of in vivo antitumor screens. The platinum-triamine complexes are typically cationic species and as such possess desirable physical properties which include high stability and solubility in aqueous media.
priorityDate 1989-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455624214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18447960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421993527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422079200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424509629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411302009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424554311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426131764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10893

Total number of triples: 63.